Escin's Action on Bradykinin Pathway: Advantageous Clinical Properties for an Unknown Mechanism?
Escin, extracted from horse chestnut (<i>Aesculus hippocastanum</i>) has anti-edema and anti-inflammatory effects. It is used to treat several clinical conditions, including venous insufficiency, pain, inflammation, and edema. Considering escin's pharmacodynamic, the inhibition of t...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , |
|---|---|
| Fformat: | Llyfr |
| Cyhoeddwyd: |
MDPI AG,
2024-09-01T00:00:00Z.
|
| Pynciau: | |
| Mynediad Ar-lein: | Connect to this object online. |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
| Crynodeb: | Escin, extracted from horse chestnut (<i>Aesculus hippocastanum</i>) has anti-edema and anti-inflammatory effects. It is used to treat several clinical conditions, including venous insufficiency, pain, inflammation, and edema. Considering escin's pharmacodynamic, the inhibition of the bradykinin pathway represents a particular effect, decreasing the local edema and conferring an advantage in comparison to other compounds. In this narrative review, we described the effects of escin considering its effects on bradykinin pathway. |
|---|---|
| Disgrifiad o'r Eitem: | 10.3390/antiox13091130 2076-3921 |